Press release
Longevity Therapeutics Market to Reach US$ 43.72 Billion by 2033, Driven by Supplements and Anti-Aging Applications | DataM Intelligence
Longevity Therapeutics Market
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/longevity-therapeutics-market?jd
North America Key Industry Developments
✅ November 2025: Elysium Health, Inc. launched a new line of NAD+ supplements targeting age-related decline.
✅ October 2025: AgeX Therapeutics, Inc. initiated clinical trials for senescence-inhibiting therapies in the U.S.
✅ September 2025: ProHealth, Inc. expanded its distribution partnerships with major retail chains across North America.
Asia-Pacific Key Industry Developments
✅ November 2025: Decode Age partnered with Chinese e-commerce platforms to scale its supplement distribution.
✅ October 2025: NanoSPACE opened a research facility in Japan focusing on advanced longevity therapies.
✅ September 2025: Gataca expanded collaborations with local health clinics to offer personalized longevity interventions.
Key Mergers and Acquisitions (2025)
✅ Strategic Expansion: T.A. SCIENCES acquired a U.S.-based nutraceutical company to enhance its supplement portfolio.
✅ Technology Acquisition: Longevity by Nature completed the acquisition of a biotech startup specializing in senescence inhibitors to strengthen its R&D capabilities.
Purchase this report before year end and unlock an exclusive 30% discount:
https://www.datamintelligence.com/buy-now-page?report=longevity-therapeutics-market
(Purchase 2 or more Reports and get 50% Discount)
Market Segmentation Analysis
By Product Type: Supplements dominate with 58.4% market share in 2024. Other therapeutics include advanced anti-aging compounds and personalized interventions.
By Application: Senescence inhibition, cardiovascular diseases, and cancer therapies drive demand for longevity therapeutics.
By Distribution Channel: Pharmacies, online channels, and retail stores remain primary distribution avenues, with online sales rapidly increasing.
Regional Insights
North America leads due to well-established nutraceutical infrastructure and high adoption of anti-aging therapeutics. Asia-Pacific is the fastest-growing region, driven by increasing consumer health awareness and government initiatives supporting nutraceutical and longevity research.
Growth Drivers
1. Rising global demand for anti-aging and healthspan-enhancing therapies
2. Expanding supplement and nutraceutical markets
3. Increasing prevalence of age-related diseases and chronic conditions
4. Technological advancements in senescence inhibition and regenerative therapies
5. Strategic partnerships and expansions by key players in North America and Asia-Pacific
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/longevity-therapeutics-market?jd
Key Players
The market includes leading companies such as Decode Age, Zeroharm, Gataca, Longevity by Nature, ProHealth, Inc., Xandro Lab., NanoSPACE, AgeX Therapeutics, Inc., T.A. SCIENCES, and Elysium Health, Inc.
Key Highlights (Top 5 Key Players)
1. Elysium Health, Inc. - Expanding NAD+ supplement portfolio targeting age-related health.
2. AgeX Therapeutics, Inc. - Initiating advanced clinical trials for senescence-inhibiting therapies.
3. ProHealth, Inc. - Strengthening North American distribution through retail partnerships.
4. Decode Age - Scaling operations in Asia-Pacific via e-commerce collaborations.
5. NanoSPACE - Establishing R&D facilities in Japan for longevity therapeutics.
Unlock 360° Market Intelligence with DataM Intelligence Subscription Services:
https://www.datamintelligence.com/reports-subscription?jd
Power your decisions with real time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape Analysis
✅ Company Profile Analysis
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updates
✅ Live Market & Pricing Trends
✅ Regulatory and Supply Chain Analysis
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Longevity Therapeutics Market to Reach US$ 43.72 Billion by 2033, Driven by Supplements and Anti-Aging Applications | DataM Intelligence here
News-ID: 4331084 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
U.S. Alzheimer Drugs Market Set for Explosive Growth to USD 8.84 Billion by 2031 …
Leander Texas -
The Alzheimer Drugs Market reached US$ 4.46 billion in 2023 and is expected to reach US$ 18.33 billion by 2031, growing at a CAGR of 19.4% during the forecast period 2024-2031.
The Alzheimer's drugs market growth is driven by key US-Japan collaborations and approvals, including the JCR Pharma-Acumen Pharmaceuticals partnership to develop a novel blood-brain barrier Alzheimer therapy and expanded use of Eisai/Biogen's lecanemab with new subcutaneous application and…
Micro Nuclear Reactors (MNRs) Market to Reach US$ 4,865.85 Million by 2032 at 18 …
The Micro Nuclear Reactors (MNRs) Market reached US$ 1,434.55 million in 2024 and is projected to reach US$ 4,865.85 million by 2032, growing at a CAGR of 18.26 percent during the forecast period 2025 to 2032.
Market growth is driven by increasing demand for reliable, low-carbon energy solutions, supportive government policies promoting clean power generation, and the need for decentralized power in remote and industrial applications. Micro nuclear reactors offer scalable,…
Digital Identity Solutions Market Set for Explosive Growth to US$189.92 Billion …
The Global Digital Identity Solutions Market reached US$35.50 billion in 2023, with a rise to US$42.45 billion in 2024, and is expected to reach US$189.92 billion by 2033, growing at a CAGR of 20.45% during the forecast period 2025-2033.
Market growth is driven by escalating cybersecurity threats, surging demand for secure authentication in remote work and e-commerce, and widespread adoption of biometric and blockchain-based verification. Advancements in AI-powered fraud detection, expanding…
Iron Ore Mining Market Set for Strong Growth to USD 620.7 Billion by 2031, Led b …
Leander Texas -
Iron Ore Mining Market reached US$ 330.2 billion in 2022 and is expected to reach US$ 620.7 billion by 2031, growing with a CAGR of 8.2% during the forecast period 2024-2031.
The Iron Ore Mining Market's strong growth is boosted by rising infrastructure and steel demand in the U.S. and Japan, coupled with strategic developments like Japanese firms acquiring stakes in global iron ore assets and collaborations with U.S.…
More Releases for Therapeutics
Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years.
DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Some of the…
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years.
DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,…
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611
Focused on growth…
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan.
Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Hodgkin's…
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space.
Key Takeaways from…
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant…
